1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis.

      Lancet
      Administration, Oral, Adult, Docosahexaenoic Acids, Double-Blind Method, Drug Combinations, Drug Evaluation, Eicosapentaenoic Acid, Fatty Acids, Unsaturated, therapeutic use, Female, Fish Oils, Humans, Male, Psoriasis, drug therapy, Random Allocation

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          28 patients with stable chronic psoriasis completed a trial in which they were randomly allocated to receive either 10 fish-oil capsules ('MaxEPA') or 10 placebo capsules (olive oil) daily. Patients were specifically instructed not to change their normal diet. After 8 weeks' treatment there was a significant lessening of itching, erythema, and scaling in the active treatment group, with a trend towards an overall decrease in body surface area affected. No change occurred in the placebo group.

          Related collections

          Author and article information

          Comments

          Comment on this article